# IOVANCE BIOTHERAPEUTICS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v3 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Canonical entity | alpha:company:6289015b-bbf4-4e67-b976-9e9067529b43 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/iovance-biotherapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 18 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-13T04:45:44.997664+00:00 | | Last reviewed | 2026-09-13T04:45:44.997664+00:00 | ## Identity - Legal name: IOVANCE BIOTHERAPEUTICS, INC. - Display name: IOVANCE BIOTHERAPEUTICS, INC. ## Leadership - Iain Dukes, D. Phil.: Chairman of the Board of Directors. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2. - Athena Countouriotis, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2. - Frederick G. Vogt, Ph.D., J.D.: Director, Interim Chief Executive Officer and President, General Counsel. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2. - Michael Weiser, M.D., Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2. - Ryan Maynard: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:3. - Wayne P. Rothbaum: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:3. - Wendy Yarno: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:3. - Corleen Roche: Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2. - Daniel Kirby: Chief Commercial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2. - François Nader, M.D.: Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:4. - Frederick G. Vogt, Ph.D., J.D.: Interim Chief Executive Officer and President, General Counsel. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2. - Friedrich Graf Finckenstein, M.D.: Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2. - Igor Bilinsky, Ph.D.: Chief Operating Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2. - Jean-Marc Bellemin: Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:5. - Raj K. Puri, M.D., Ph.D.: Chief Regulatory Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - IOVANCE BIOTHERAPEUTICS, INC.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:1. ## Headquarters - US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review. ## Entity Status - Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:1. ## Published Fact - US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/iovance-biotherapeutics-inc). - alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:2: [SEC DEF 14A 0001104659-26-050458](https://www.sec.gov/Archives/edgar/data/1425205/000110465926050458/iova-20260610xdef14a.htm). - alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:3: [DEF 14A iova-20250610xdef14a.htm](https://www.sec.gov/Archives/edgar/data/1425205/000155837025005702/iova-20250610xdef14a.htm). - alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:4: [IOVA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1425205/000110465926050458/iova-20260610xdef14a.htm). - alpha:evidence:company:6289015b-bbf4-4e67-b976-9e9067529b43:5: IOVA executive roster source. ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. - Current index memberships: Unavailable - Index membership events: Unavailable ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/iovance-biotherapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/iovance-biotherapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/iovance-biotherapeutics-inc) - [JSON-LD](https://registry.alpha.ac/api/public/companies/iovance-biotherapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/iovance-biotherapeutics-inc` at https://mcp.alpha.ac/mcp